WHO guidance incorporates Good Clinical Trials Collaborative’s work
Principles from global community initiative, which includes Protas, forms basis of new WHO guidance.
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Principles from global community initiative, which includes Protas, forms basis of new WHO guidance.
A new article by Protas, Duke and CTTI explores how clinical trials can generate better evidence.
Protas has played a significant role in shaping three major policy efforts.
Nick Medhurst shares the Good Clinical Trials Collaborative’s work and vision.
Maggie Payne has joined the Executive Team responsible for the leadership of Protas.
Working in our IT Team, Kieran Hamilton shares how Protas is making use of data and tech.
Protas announces the launch of its new Cantata platform.
A new webinar with Protas and colleagues explores new ICH guidance for clinical trials.
Emma Law, Head of Clinical Quality Assurance, writes for The Research Quality Association (RQA).
Jen Dumbleton talks about her role at Protas and our mission to create smarter, better trials.
Protas colleagues have published a new article exploring what COVID-19 taught us about improving clinical trial design.
Jen Dumbleton explores novel ways to improve the success rate of large RCTs.